Facebook Twitter LinkedIn Instagram Email Printer Google Plus

COVID-19

Executives discuss the COVID-19 financial fallout and what future subsequent peaks might look like for health systems.

Market dynamics are ripe for M&A activity. But before being enticed by a mirage, leaders must revisit old lessons.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Chinese platforms and service providers are experiencing a spike in tech adoption and utilization amidst the pandemic.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

The coronavirus is transforming the status quo of cost, sustainability, and affordability.

Partner, Health & Life Sciences, Oliver Wyman
Global Head, Provider, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

The aviation and finance industries' past experiences accessing federal programs mirror providers' current experiences.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Four tactical considerations to ensure your pandemic reaction is expedited, purposeful, and meaningful.

Principal, Health & Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A closer look at how new healthcare reform is helping providers navigate COVID-19's uncertainty.

Partner, Nixon Peabody
Partner, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Global Head, Provider, Health & Life Sciences, Oliver Wyman

For coronavirus patients, and all patients, being without a bed means being without a place to go.

Principal, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Six strategies to optimize care while protecting those on the front lines of battling COVID-19.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Urgent action items to ensure COVID-19 patients, and all patients, are directed to the right place at the right time.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe